Arcturus Therapeutics Holdings Receivables

Arcturus Therapeutics Holdings (ARCT) currently reports a receivables of $1.8M as of June 2026. That compares with $17M in the prior-year period — down 89.5% year over year. Use the charts on this page to explore Arcturus Therapeutics Holdings's receivables history and peer comparisons.

Arcturus Therapeutics Holdings's receivables decreased from $17M to $1.8M — a 89.5% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Arcturus Therapeutics Holdings reported $1.8M in receivables as of June 2026. That compares with $17M in the prior-year period — down 89.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $1.8M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Arcturus Therapeutics Holdings, and consider following ARCT for alerts when major investors trade the stock.

Arcturus Therapeutics Holdings is classified in the Healthcare sector. On receivables, it currently shows $1.8M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ARCT with unrelated industries.